Episode 62 - The role of angioedema in the treatment of CSU

Professor Marcus Maurer is accompanied by Professor Marc Riedl to delve into the symptomatology and pathophysiology of angioedema in chronic spontaneous urticaria (CSU). The mechanistic aetiology of angioedema within the context of CSU pathology is also explored. Professor Marc Riedl examines therapeutic treatments for patients concurrently experiencing angioedema in CSU while exploring how the characterisation of autoimmune and auto allergic pathophysiological mechanisms can impact treatment decisions. Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here. For more information on all UCARE activities please visit: https://ga2len-ucare.com/ and utilise the following external links to access additional resources relating to the topics discussed in this episode: Angioedema - Ten Questions, Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema, WAO/EAACI guideline for HAE, The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria, and Consensus on treatment goals in hereditary angioedema. For more information about the UCARE/ACARE network and its activities, please visit: UCARE Website, UCARE LevelUp Program, ACARE Website, UCARE 4U Website, UDAY Website, CRUSE Control App and CURE Registry.

There are no comments yet.

Please log in to write the first comment.